Verified earnings results
Sarepta Therapeutics Q3 2026 Earnings Results
Direct answer
Sarepta Therapeutics reported Q3 2026 results on November 5, 2026.
Revenue was 381,350,000. EPS beat the estimate by 99.39%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 5, 2026
- Reported timing
- After the US market closes
- EPS estimate
- 0.0652
- Reported EPS
- 0.13
- Revenue
- 381,350,000
- EPS surprise
- EPS beat the estimate by 99.39%.
Explore related company data
Read the frequently asked questions.
When did Sarepta Therapeutics report Q3 2026 earnings?
Sarepta Therapeutics reported on November 5, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Sarepta Therapeutics?
The verified record provides an EPS estimate of 0.0652.
Has Sarepta Therapeutics reported the Q3 2026 result?
Revenue was 381,350,000. EPS beat the estimate by 99.39%.
Which source supports this Sarepta Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.